Colin Edwards Email & Phone Number

Columbus, Ohio Metropolitan Area

• Member of the Transcatheter Heart Valve (THV) Medical Affairs Scientific Communications team
• Proactively prioritize, identify, assess, and critically summarize relevant scientific and medical literature across the THV therapeutic area, including the SAPIEN 3 Ultra and SAPIEN 3 Ultra RESILIA aortic valves and.
• Collaborate with physician investigators and other healthcare professionals in the development of scientific communications content, such as conference proceedings (abstracts and presentations) and manuscripts
• Conduct literature reviews to address internal and external THV medical information queries
• Collaborate with physician investigators on analysis of Society of Thoracic Surgeons (STS)/American College of Cardiology (ACC) Transcatheter Valve Therapy (TVT) Registry and other data and the presentation/publication.
• Lead the maintenance and continued development of the global scientific content repository

Columbus, Ohio, United States

• Key member of the Clinical and Medical Affairs global Scientific Communications team, crafting manuscripts, abstracts, and presentations. Provide consultation to Clinical Operations, R&D, Regulatory, and Marketing for.
• Provide scientific, medical, and clinical review for internal and external projects, including cross-functional partnerships with Sales, Marketing, R&D, Regulatory, and Legal departments. Conduct literature reviews and.
• Manage global off-label use response program, training 2,300 employees in the commercial team and in Clinical and Medical Affairs with >95% completion rate. Maintain off-label use response tracking system and re-wrote.

Columbus, Ohio Area

Mentored internal/external investigators and coordinated national system-level research (involving from three to 94 hospitals). Provided consultations and monitored research projects for Trinity Health employees across the system who were planning research activities, including literature review, protocol development, statistical methodology development.

Columbus, Ohio Area

Directed research activity at 4 Mount Carmel hospitals and NCI clinical trials at outpatient cancer center. Oversaw department operating budget and clinical research activity across healthcare system, including 175 clinical trials and registries for physician investigators, 90 research and quality improvement projects for resident physicians, fellows.

Westerville, OH

Managed and coordinated all clinical research activity, with involvement from initial concept through FDA approval of DirectVision® visually-guided urinary catheter placement system. Coordinated research collaborations with local and national physician investigators and healthcare organizations; conducted literature searches; designed and wrote clinical.

Provided strategic leadership to Cancer and Leukemia Group B (CALGB) Cytogenetics Data Management Center, an NCI cooperative group. Oversaw leukemia patient protocol eligibility determination and chemotherapy regimen stratification for 5 national/international Phase II/III clinical trials, based on chromosomal abnormalities, genetic mutations, and cell.

Collected and entered clinical data. Set up data management center at new location, which involved transferring research charts and large database, as well as hiring data management and administrative staff, while supporting physician investigator. Co-authored 2 abstracts and granted co-authorship on manuscript (1999).

Columbus, OH

Served as Lead Clinical Research Associate for national Prostate Cancer Prevention Trial for main member institution (OSU) and 7 affiliate institutions. Managed local clinical trial activities, including clinical trial patient screening and follow-up, quality assurance activities, and blood and pathology specimen processing.

Ph.D., Public Health / Epidemiology

Doctoral dissertation research: “Exposure to Loud Noise and Risk of Acoustic Neuroma.” Studied risk factors for acoustic neuroma, a benign.

M.S., Preventive Medicine

Master’s thesis: “A Case-Control Study of Risk Indicators for Methicillin-Resistant Staphylococcus aureus (MRSA) in a Medical Intensive.

B.S., Microbiology (Minor In German)